Monument Therapeutics

Cambridge, United Kingdom

Monument Therapeutics used digital biomarkers to develop innovative new drugs for neuropsychiatric disorders including schizophrenia

Feb 2026

Venture - Series Unknown

Biopharma Biotechnology Health Care Life Science Pharmaceutical

Top Investors

SyndicateRoom Innovate UK ACF Investors GM&C Life Sciences Fund One Mind Accelerator

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Monument Therapeutics

Who are Monument Therapeutics's investors?

Monument Therapeutics's investors include SyndicateRoom, Innovate UK, ACF Investors, GM&C Life Sciences Fund, One Mind Accelerator.

Where is Monument Therapeutics headquartered?

Monument Therapeutics is headquartered in Cambridge, United Kingdom.

What does Monument Therapeutics do?

Monument Therapeutics used digital biomarkers to develop innovative new drugs for neuropsychiatric disorders including schizophrenia

What stage is Monument Therapeutics at?

Monument Therapeutics is at the Venture - Series Unknown stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated February 9, 2026.

MLA

"Monument Therapeutics — Funding & Investors." VCBacked, February 9, 2026, https://www.vcbacked.co/company/monument-therapeutics. Accessed July 2, 2026.

APA

VCBacked. (2026). Monument Therapeutics — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/monument-therapeutics

Wikipedia (cite web)

{{cite web |title=Monument Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/monument-therapeutics |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated February 9, 2026.